journal article·2019-12-04Open access

Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS)

Yinghui Zhao, Mei Tao, Meiling Wei, Shengye Du, Hongping Wang, Xiaohong Wang

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous reproductive disease. Adipose mesenchymal stem cells (AMSCs) can produce a mass of exosomes. The objective of this study was to determine the effects of exosomal miR-323-3p on cumulus cells (CCs) of PCOS patients. Exosomal miR-323-3p were collected from modified AMSCs. Real-time PCR, western blots, MTT assays, flow cytometry, luciferase reporter assays and a letrozole-induced PCOS mouse model were used to identify mechanisms of exosomal miR-323-3p on CCs. The results revealed that miR-323-3p expression was upregulated in AMSCs, exosomes and CCs. Upregulated miR-323-3p promoted cell proliferation and suppressed apoptosis in CCs, while miR-323-3p inhibitor exerted opposite roles in exosome-treated CCs. Moreover, PDCD4 was upregulated in PCOS CCs, displayed an inverse expression pattern to those of miR-323-3p, and was a direct target of miR-323-3p. Overexpression of PDCD4 reversed the effects of upregulated miR-323-3p on CCs. Serum FSH, LH and testosterone were upregulated while E2 levels were downregulated in the PCOS mice. Upregulation of miR-323-3p alleviated PCOS by suppressing CCs’ apoptosis through targeting PDCD4 in vivo. The results demonstrated that exosomal miR-323-3p promoted cell proliferation and inhibited apoptosis in CCs through targeting PDCD4 in PCOS. This study provides insight into developing new therapeutic strategies for PCOS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ovarian function and disorders · Reproductive Biology and Fertility · Reproductive System and Pregnancy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Gynecology Department, Jinan City People Hospital

References (46)

Show source-provided references
1. 10.1038/nrdp.2016.5710.1038/nrdp.2016.57 ↗
2. 10.2174/13816121280330759010.2174/138161212803307590 ↗
3. 10.1210/er.2011-103410.1210/er.2011-1034 ↗
4. 10.1210/jc.2005-149410.1210/jc.2005-1494 ↗
5. 10.1210/jc.2005-062810.1210/jc.2005-0628 ↗
6. 10.1111/j.1365-2265.2010.03956.x10.1111/j.1365-2265.2010.03956.x ↗
7. 10.1210/jc.2007-165010.1210/jc.2007-1650 ↗
8. 10.1093/humupd/dmm04010.1093/humupd/dmm040 ↗
9. 10.1007/s00404-017-4523-510.1007/s00404-017-4523-5 ↗
10. 10.1093/molehr/7.4.32510.1093/molehr/7.4.325 ↗
11. 10.1038/nrg245510.1038/nrg2455 ↗
12. 10.1002/jcp.2199910.1002/jcp.21999 ↗
13. 10.1210/jc.2013-171510.1210/jc.2013-1715 ↗
14. 10.1016/j.rbmo.2015.06.02310.1016/j.rbmo.2015.06.023 ↗
15. 10.4161/cib.3.5.1233910.4161/cib.3.5.12339 ↗
16. 10.1073/pnas.091484310710.1073/pnas.0914843107 ↗
17. 10.1186/s13045-015-0181-x10.1186/s13045-015-0181-x ↗
18. 10.2174/15665231280208359410.2174/156652312802083594 ↗
19. 10.1016/j.addr.2012.07.00110.1016/j.addr.2012.07.001 ↗
20. 10.1002/stem.112910.1002/stem.1129 ↗
21. 10.1111/jcmm.1317010.1111/jcmm.13170 ↗
22. 10.1186/s13045-015-0220-710.1186/s13045-015-0220-7 ↗
23. 10.1373/clinchem.2011.17928310.1373/clinchem.2011.179283 ↗
24. 10.1007/s00296-013-2767-310.1007/s00296-013-2767-3 ↗
25. 10.1016/j.gene.2018.10.00610.1016/j.gene.2018.10.006 ↗
26. 10.1016/j.fertnstert.2003.10.00410.1016/j.fertnstert.2003.10.004 ↗
27. 10.1089/scd.2006.011810.1089/scd.2006.0118 ↗
28. 10.1016/j.diff.2013.02.00110.1016/j.diff.2013.02.001 ↗
29. 10.18632/oncotarget.2473710.18632/oncotarget.24737 ↗
30. 10.1007/s00109-008-0403-610.1007/s00109-008-0403-6 ↗
31. 10.1038/celldisc.2017.2210.1038/celldisc.2017.22 ↗
32. 10.1371/journal.pone.014650910.1371/journal.pone.0146509 ↗
33. 10.1056/NEJMra04153610.1056/NEJMra041536 ↗
34. 10.1016/S0140-6736(07)61345-210.1016/S0140-6736(07)61345-2 ↗
35. 10.1016/j.gene.2014.08.04110.1016/j.gene.2014.08.041 ↗
36. 10.1038/mt.2016.9010.1038/mt.2016.90 ↗
37. 10.1002/stem.256410.1002/stem.2564 ↗
38. 10.2147/OTT.S14331510.2147/OTT.S143315 ↗
39. 10.1517/14728222.2014.85520110.1517/14728222.2014.855201 ↗
40. 10.1038/srep0868910.1038/srep08689 ↗
41. 10.1373/clinchem.2010.14766010.1373/clinchem.2010.147660 ↗
42. 10.1016/j.biolcel.2003.09.00310.1016/j.biolcel.2003.09.003 ↗
43. 10.1128/MCB.24.9.3894-3906.200410.1128/MCB.24.9.3894-3906.2004 ↗
44. 10.1002/(SICI)1098-2795(199811)51:3<243::AID-MRD3>3.0.CO;2-P10.1002/(SICI)1098-2795(199811)51:3<243::AID-MRD3>3.0.CO;2-P ↗
45. 10.1016/j.fertnstert.2016.01.02010.1016/j.fertnstert.2016.01.020 ↗
46. 10.1093/humrep/15.9.188910.1093/humrep/15.9.1889 ↗